News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Opinion Editor's Corner ESC 2016 My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance Shelley Wood September 08, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
Presentation ESC 2016 “Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX Presenter: Deepak L. Bhatt August 31, 2016
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18 Todd Neale August 30, 2016
Presentation ESC 2016 PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI Presenter: Zuzana Motovska August 30, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades Shelley Wood August 29, 2016
News Conference News ESC 2016 Screening for and Treating Asymptomatic Extracoronary Disease No Help in High-risk CAD Todd Neale August 29, 2016
News Conference News ESC 2016 Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2 Michael O'Riordan August 29, 2016
News Conference News ESC 2016 Treating Sleep Apnea Fails to Boost Outcomes in Patients With CVD: SAVE Trial Todd Neale August 28, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Conference News ESC 2016 NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months Michael O'Riordan August 28, 2016
Presentation ESC 2016 NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment Presenter: Masato Nakamura August 28, 2016
Presentation ESC 2016 ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications Presenter: Gilles Montalescot August 28, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care L.A. McKeown September 02, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015